GURUFOCUS.COM » STOCK LIST » USA » NYSE » Boston Scientific Corp (NYSE:BSX) » Definitions » EV-to-EBIT
Switch to:

Boston Scientific EV-to-EBIT

: 41.98 (As of Today)
View and export this data going back to 1992. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Boston Scientific's Enterprise Value is $67,968 Mil. Boston Scientific's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $1,619 Mil. Therefore, Boston Scientific's EV-to-EBIT for today is 41.98.

The historical rank and industry rank for Boston Scientific's EV-to-EBIT or its related term are showing as below:

BSX' s EV-to-EBIT Range Over the Past 10 Years
Min: -2577.3   Med: 37.87   Max: 1281.98
Current: 41.98

During the past 13 years, the highest EV-to-EBIT of Boston Scientific was 1281.98. The lowest was -2577.30. And the median was 37.87.

BSX's EV-to-EBIT is ranked worse than
82.5% of 440 companies
in the Medical Devices & Instruments industry
Industry Median: 19.35 vs BSX: 41.98

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Boston Scientific's Enterprise Value for the quarter that ended in Mar. 2022 was $72,672 Mil. Boston Scientific's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $1,619 Mil. Boston Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was 2.23%.


Boston Scientific EV-to-EBIT Historical Data

The historical data trend for Boston Scientific's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Boston Scientific Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
EV-to-EBIT
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.94 33.56 63.05 208.27 48.05

Boston Scientific Quarterly Data
Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 74.76 42.96 48.05 50.29 -

Competitive Comparison

For the Medical Devices subindustry, Boston Scientific's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Boston Scientific EV-to-EBIT Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Boston Scientific's EV-to-EBIT falls into.



Boston Scientific EV-to-EBIT Calculation

Boston Scientific's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=67968.290/1619
=41.98

Boston Scientific's current Enterprise Value is $67,968 Mil.
Boston Scientific's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boston Scientific  (NYSE:BSX) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Boston Scientific's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2022 ) =EBIT / Enterprise Value (Q: Mar. 2022 )
=1619/72672.3266
=2.23 %

Boston Scientific's Enterprise Value for the quarter that ended in Mar. 2022 was $72,672 Mil.
Boston Scientific's EBIT for the trailing twelve months (TTM) ended in Mar. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,619 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Boston Scientific EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Boston Scientific's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Boston Scientific Business Description

Boston Scientific logo
Address
300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, cardiac rhythm management, catheter-directed ultrasound imaging, structural heart disease, upper gastrointestinal tract diagnostics, interventional oncology, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for nearly half of the firm's total sales.
Executives
Wichmann David S director UNITEDHEALTH GROUP INC 9900 BREN RD E MINNETONKA MN 55343
Brown Vance R officer: SVP, GC and Corp. Secretary C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Olson Scott officer: SVP & Pres, Rhythm Management C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Scanlon Meghan officer: SVP,Pres,Urology Pelvic Health C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Monson Jonathan officer: VP, Corp Controller and CAO C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Fujimori Yoshiaki director 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
James Donna director ONE MIRANOVA PLACE SUITE 1040 COLUMBUS OH 43215
Zane Ellen M director C/O TUFTS-NEW ENGLAND MEDICAL CENTER 750 WASHINGTON STREET, TUFTS-NEMC #451 BOSTON MA 02111
Sununu John E director C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Connors Nelda J director BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234
Ludwig Edward J director C/O BECTON DICKERSON & CO 1 BECTON DR FRANKLIN LAKES NJ 07417
Roux David J director C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752
Dockendorff Charles J director COVIDIEN LTD. 15 HAMPSHIRE STREET MANSFIELD MA 02048
Macmillan Stephen P director 250 CAMPUS DRIVE MARLBOROUGH MA 01752
Wang Xin Warren officer: SVP and Pres, Asia Pacific C/O BOSTON SCIENTIFIC CORPORATION 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752

Boston Scientific Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)